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Abstract
Epithelial-mesenchymal transition (EMT) is an important process in tumor metastasis. The EMT-
related events associated with metastasis of NPC in the absence of EBV have not been elucidated.
We established an EBV-negative NPC cell line from a bone marrow biopsy of an NPC patient. Using
a Matrigel system we isolated an invasive and non-invasive sublines, designated NPC-BM29 and
NPC-BM00. NPC-BM29 acquired an invasive-like phenotype characterized by EMT, marked by
down-regulation of E-cadherin and β-catenin with concomitant increased expression of Ets1. NPC-
BM29 cells expressed ≥ 10-fold higher of MMP-9 than NPC-BM00 cells. NPC-BM29 cells grew
better in 2% serum than NPC-BM00 cells, with a population doubling-time of 26.8 h and 30.7 h,
respectively. A marked reduction in colony-formation ability of NPC-BM00 cells compared to
NPC-BM29 was observed. Wound-healing assay revealed that NPC-BM29 cells displayed higher
motility than NPC-BM00 and the motility was further enhanced by cell treatment with TPA, a PKC
activator. Cell surface markers and tumor-associated molecules, AE3, MAK6 and sialyl-Tn, were
up-regulated in NPC-BM29 cells, whereas the expression of HLA-DR and CD54 was significantly
increased in NPC-BM00 cells. NPC-BM29 consistently released higher levels of IL-8 and IL-10 than
NPC-BM00, with low levels of IL-1α expression in both cell lines. Higher level of VEGF production
was detected in NPC-BM00 than NPC-BM29 cells. These data show that EBV is not required for
exhibiting multiple metastatic phenotypes associated with EMT. More studies that target right
molecules/signalings associated with the EMT may offer new therapeutic intervention options for
NPC invasion and metastasis.
Published: 24 November 2009
Journal of Biomedical Science 2009, 16:105 doi:10.1186/1423-0127-16-105
Received: 23 June 2009
Accepted: 24 November 2009
This article is available from: http://www.jbiomedsci.com/content/16/1/105
© 2009 Lin et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The cost of publication in Journal of Biomedical Science
is bourne by the National Science Council, Taiwan.Journal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
Page 2 of 14
(page number not for citation purposes)
Introduction
Nasopharyngeal carcinoma (NPC) is an Epstein-Barr virus
(EBV)-associated malignant tumor. NPC is latently
infected with the virus, and monoclonal EBV episomes are
present and expressed in the tumor cells in both endemic
and sporadic forms of NPC, regardless of geographic ori-
gin [1,2]. A prominent clinical characteristic of NPC is fre-
quent involvement of cervical lymph nodes and distant
organs compared with other head and neck carcinomas
[3-6]. Among head-and-neck cancers, NPC is distin-
guished by its highly metastatic character and poor prog-
nosis [6].
Epithelial to mesenchymal transition (EMT) is a process
that was first observed in embryonic development [7] and
has more recently been implicated as an underlying event
in neoplastic progression [8,9]. EMT is characterized by
the loss of epithelial markers and gain of mesenchymal
markers, often identified in cell lines established from
tumors representing different stage and grade [10,11].
Metastatic spread of cancer cells is a result of a complex
cascade of cellular/molecular events. The cascade is com-
posed of multiple sequential steps such as down-regula-
tion of intercellular adhesion, degradation of extracellular
matrix (ECM) and up-regulation of cell motility. In addi-
tion, tumor size and likelihood of metastasis are thought
to depend on increased vascularity in tumors [12].
Tumor metastasis is a complex phenomenon that is the
culmination of effects of numerous cellular factors. Recent
studies have shown that latent membrane protein 1
(LMP-1) of EBV induces the expression of a series of cell-
invasiveness and angiogenic factors, such as matrix metal-
loproteinase 9 (MMP9) [13], MMP1 and MMP3 [14], c-
Met and ets-1 [15], fibroblast growth factor 2 [16], vascu-
lar endothelial factor [17], hypoxia-inducible factor 1a
[18], MUC1 [19], Siah 1 [20], Twist [21] and ezrin [22].
However, unlike in vivo growth, EBV genome is com-
monly lost during the establishment of NPC cell lines
from biopsies or xenografts [23], implying that EBV is not
necessary for maintaining the growth of carcinoma cells in
vitro. Lack of suitable EBV-negative NPC cell lines with
metastatic potential leads to poor understanding of the
molecular events associated with NPC metastasis.
In this study we first attempted to separate the invasive
and non-invasive populations from an EBV-negative NPC
tumor cell line derived from a bone marrow lesion [24].
Secondly, we characterized the EMT morphologic changes
and identified the underlying biomarkers linked to EMT
that were associated with the invasiveness and metastasis.
Materials and methods
Cell lines and culture
NPC-BM1 is an epithelial cell line established from a bone
marrow biopsy of a female Taiwanese patient with NPC
[24]. The cells were originally propagated in RPMI-1640
medium but were adapted to growth in Dulbecco's mod-
ified Eagle medium (DMEM) supplemented with 2 mM L-
glutamine, 0.1 mM non-essential amino acids plus 100
IU/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/ml
amphotericin (GIBCO, CA, USA) and 10% heat inacti-
vated fetal bovine serum (FBS).
Matrigel invasion assay
To separate the invasive from non-invasive cells, the Bio-
Coat Matrigel Invasion Chambers (Becton Dickinson, CA,
USA) was used according to the manufacturer's protocol.
Briefly, NPC-BM1 cells (1 × 105 per well) were seeded
onto the filters which were coated with the reconstituted
Matrigel layered at the upper compartment of each cham-
ber and incubated with DMEM medium. The lower cham-
ber was filled with DMEM medium supplemented with
2% FBS. The chambers were then incubated for 48 h at
37°C. After incubation, cells on the upper side of the fil-
ters were considered as being populated by non-metasta-
sizing cells. Cells in the lower surface of the filter were
considered to have invaded through the Matrigel and
thereby had metastasized.
To determine the invasive potential, cells were seeded on
Matrigel and control chambers. The numbers of cells on
the lower surfaces were stained with Diff-Quick solution
(Sigma Chemical Company, MO, USA) and counted. The
percent invasion is determined by:
Detection of EBV genome
To detect EBV DNA in NPC-BM1, NPC-BM00 and NPC-
BM29, we used primers specific for the BamHI W region
and EBNA-3C by polymerase chain reaction as described
previously [25,26]. The genomic DNA isolated from NPC-
BM1, NPC-BM00 and NPC-BM29 cells were analyzed in
parallel with B95-8 (EBV type A strain) and AG876 (type
B strain) cells. Primers flanking the β-globin  gene were
used as an internal control.
Anchorage-independent growth assay
Anchorage-independent cell growth was examined by
using a soft agar assay. The assay was done in 24-well
plates with a base layer containing 1.0% agar in DMEM.
Then, different cell numbers (1250, 2500, 5000 and
10000) in 0.6% agar in DMEM containing different con-
centrations of FBS ranging from 1.25 to 10% were embed-
ded as a second layer. The plates were incubated at 37°C
Mean # of cells invading through Matrigel insert membrane
Me ean # of cells migrating through control insert membrane
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for 6 days and the number of colonies after staining was
counted. Data are presented as the means ± standard devi-
ation from experiments that were performed in triplicate
wells for each time point.
Growth Rate Determination
To determine the growth rate in high (10%) and low (2%)
serum conditions, cells were seeded onto a 6-well plate (5
× 104 cells per well). The cells were trypsinized and viable
cells were counted daily for 8 d with the trypan blue assay
in triplicate. Growth curves were plotted. The doubling
times were calculated at the exponential phase of growth
cycle.
Scrape-wound migration assay
To determine the cell motility, confluent monolayers were
scraped by using a plastic pipette tip. Cells that had
migrated into the scraped area were observed 7 h later. To
determine the effects of tumor promoting agent TPA (12-
O-tetradecanyol-phorbol-13-acetate) on cell migration,
cells were seeded onto 6-well plates at 5 × 105 cells per
well in DMEM with 10% FBS. The confluent monolayers
were treated with 30 ng/ml of TPA [27,28] for 24 h fol-
lowed by scrape-wounding the cells which were then stud-
ied 7 h after scraping.
Gelatin Zymography
Matrix metalloproteinase-2 (MMP-2) and MMP-9 were
assayed for gelatinolytic activity by means of gelatin
zymography as reported previously [13]. Briefly, cells
were cultured in DMEM containing10% FBS for 3 d. The
conditioned media were harvested. Following low-speed
centrifugation, the supernatants were concentrated by pre-
cipitation with 70% saturated ammonium sulfate. The
precipitates were harvested by centrifugation and then
were dissolved in phosphate-buffered saline (PBS) and
mixed with Lammli's sample buffer (50 mM Tris-HCl, pH
6.8, 10% glycerol, 1% SDS, and 0.01% bromophenol
blue) in the absence of a reducing agent; these steps were
taken to denature MMPs and to dissociate any complexes
with tissue inhibitors of metalloproteinases. The mixture
was then incubated at 37°C for 20 min. and SDS-polyacr-
ylamide gel electrophoresis (containing gelatin at a final
concentration of 0.1%) was performed. After electro-
phoresis, the gel was rinsed in 2.5% Triton X-100 for 1 h
and then incubated for 24 h at 37°C in a solution contain-
ing 50 mM Tris-HCl, pH 7.6, 150 mM NaCl, 10 mM CaCl2
and 0.02% NaN3. The MMPs were identified following
staining of the gel in 0.1% Coomassie blue R250 dis-
solved in 40% methanol-10% acetic acid and destaining
in the same solution without Coomassie blue. Gelatino-
lytic activity was visualized as a clear band against a dark
background of stained gelatin.
Western blotting
This was performed to detect proteins involved in EMT (E-
cadherin, β-catenin, and Ets1). Cells were lysed with a cell
lysis buffer containing 10 mM Tris-HCl (pH 7.4), 100 mM
NaCl, 1 mM EDTA, 0.5% deoxycholate, 1% Triton X-100,
and 1 mM phenylmethylsulfonyl fluoride. The quantity of
protein in the cell lysate after centrifugation was measured
with a protein assay kit (Bio-Rad). The proteins were
resolved by electrophoresis with a 10% SDS-polyacryla-
mide gel and transferred onto a PVDF membrane (Perkin-
Elmer, CT, USA). The membrane was blocked with 5%
non-fat dry milk in Tris-buffered saline, pH 7.4 containing
0.1% Tween-20 before incubation with antibodies over-
night at 4°C, after which the blots were washed with PBS
containing 0.05% Tween-20 (PBST) and further incu-
bated with horseradish peroxidase-conjugated secondary
antibodies (1:3000 dilutions) for 1 h at room tempera-
ture. Specific blot signals were visualized on an X-ray film
by incubating with ECL-Plus chemiluminescence kit (Per-
kin-Elmer, CT, USA). The primary antibodies against E-
cadherin, β-catenin, and Ets1 were purchased from Santa
Cruz Biotechnology, Inc, CA, USA, and used at a dilution
of 1:2000 for E-cadherin and β-catenin, and 1:100 for Ets-
1.
Immunophenotyping
Various cellular components were examined for surface
and cytoplasmic expression by immunofluorescence and
flow cytometry using a panel of specific monoclonal anti-
bodies (mAbs) including anti-HLA-A, B, C (clone W6/32;
BD-PharMingen; San Diego, CA), HLA-DR (DK22,
DAKO, Glostrup, Denmark), EMA (E29, DAKO), AE1
(462-01, Signet, Dedham, MA, USA), AE3 (464-01, Sig-
net), MAK6 (28-001, Zymed, San Francisco, CA, USA),
CK7 (OV-TL12/30, DAKO), CK20 (KS20.8, DAKO),
EpCAM (323/A3, Thermo Scientific, Fermont, CA, USA),
E-cadherin (67A4, Biodesign, Saco, ME, USA), Sialyl-Tn
(49H.8; Dr. BM Longrenecker, Biomira, Edmonton, CA,
USA), Lewis Y (Ley; ABL364; Dr H Loibner, Sandoz,
Vienna, Austria); BH8.23 (Epthelial cell-associated anti-
gen, Mr: 50-55 kDa,. S-K Liao, unpublished), CEA (COL-
1, NEOMAKERS, Fremont, CA, USA), vimentin (V9;
DAKO); VEGF (G153-694; BD-PharMingen), CD44s
(SFP22; BenderMed System, Vienna, Austria), CD54
(6.5B5; DAKO); and CD58 (AICD58, Beckman Coulter,
Brea, CA, USA). The final working concentrations of these
reagents used in immunofluorescence and flow-cytomet-
ric analysis were 5 μg/ml or diluted to a concentration
according to the manufacturer's instructions.
Cells harvested from cultures were washed with PBS con-
taining 2% FBS. For cytoplasmic expression, cells were
first fixed by 1% paraformaldehyde at 4°C for 20 min, fol-
lowed by permeablization with pre-cold acetone for 3
min. Cells were incubated with specific primary mAb forJournal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
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30 min at 4°C. After washing, cells were then incubated
with fluorescein-isothioeyanate (FITC)-conjugated goat
anti-mouse IgG polyclonal antibodies (DAKO) for 30 min
at 4°C. For surface antigen expression, viable singly dis-
persed cells were directly incubated with the primary
mAb. Following a brief washing, cells were incubated with
FITC-conjugated goat polyclonal Ab as for cytoplasmic
antigen staining. After washing off the excess Ab, cells for
both surface and cytoplasmic antigens were fixed with 1%
paraformaldehyde and then analyzed on a FACscan flow
cytometry machine (Becton Dickinson Co., CA, USA) to
determine the level of immunofluorescent signal quanti-
tatively. The results were expressed as % positive cells and
relative mean fluorescence intensity (MFI). Proper con-
trols were used such as replacing the second antibodies
with PBS, and replacing the primary mAb with purified
normal mouse IgG (NMIgG) or an isotype-matched mon-
oclonal mouse IgG.
Immunohistochemistry
Sections (5-μm in thickness) of OCT embedded tumor
blocks obtained from xenografts were placed on gelatin-
coated slides, air dried, and fixed in chilled acetone (4-
5°C). Slides were washed once in PBS and stained with
mAbs using tha Avidin-biotin-peroxidase complex (ABC)
methods (Vectastain ABC kit, Vector Laboratories, Burl-
ington, CA) according to mauufacturer's instructions.
Results were scored as described previously (32). To per-
form immunocytochemistry on acetone-fixed cytospin
cells of monodispersed bone marrow cells from the NPC
patients, similar immunostaining procedure for xenograft
tissues was used.
Cytokine array
To compare the expression levels of cytokines associated
with tumor cell growth, the following cytokines in the Q-
Plex™ Human Cytokine Array (Quansys Biosciences, San
Diego, CA, USA) were measured: IL-1α, IL-1β, IL-2, IL-4,
IL-5, IL-6, IL-8, IL-10, IL-13, IFN-γ, TNF-α, and TNF-β. The
kit provides 12 distinct capture antibodies absorbed to
each well of a 96-well plate in a defined array. Once the
ELISA protocol was completed, the Q-Plex™ Array was
imaged using a CCD imaging system (Vilber Lourmat,
France) to capture the chemiluminescent signal. Similarly,
VEGF was separately analyzed by a VEGF ELISA kit (R&D
Systems, Minneapolis, MN). The assay was applied to
media from cells that had been cultured with serum-free
DMEM sampled on d 1, 3, and 5.
Statistical analysis
The data represent the mean ± standard deviation from 3
independent experiments. Statistical analyses were per-
formed by using 2-tailed Student t tests at a significance
level of p < .05
Results
Isolation of invasive cell populations
Although NPC-BM1 originated from the bone marrow,
the primary site was in the nasopharyngeal cavity. To
assess the metastatic potential of this tumor cell, we
attempted to separate the cells possessed invasive charac-
teristics from those that did not possess such characteris-
tics. We used the Matrigel Invasion Assay System which
provides cells with the conditions that allow assessment
of their invasive property in vitro. Under these assay con-
ditions, we have isolated a subline, NPC-BM18, from cells
that had migrated to the lower surface of the filter. The
cells remained on the upper surface of the membrane was
considered as non-invasive cells and were designated
NPC-BM00. The NPC-BM18 subline was expanded and
further subjected to one more round of selection through
Matrigel; the resulting cells were designated NPC-BM29.
NPC-BM29 (Fig. 1 panel A) exhibited higher invasive
capability than that of NPC-BM18 (panel C), while the
parental cells NPC-BM1 (panel D) showed moderate
capability of invasion. However, only limited numbers of
NPC-BM00 cells (panel B) were able to migrate to the
Selection of invasive cells by Matrigel Invasion Chambers Figure 1
Selection of invasive cells by Matrigel Invasion Cham-
bers. NPC-BM1 cells were seeded onto the filters which 
were coated with the reconstituted Matrigel of the upper 
compartment of each chamber and incubated with DMEM. 
After incubation, cells on the upper side of the filters were 
removed and cells in the lower surface of the filter were 
stained with Diff-Quick solution for counting. A, invasive 
cells (NPC-BM18) after the first round of selection; B, non-
invasive cells (NPC-BM00); C, invasive cells (NPC-BM29) 
after the second round of selection; D, the parental cells 
(NPC-BM1).
AB
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lower surface of the membrane. A quantitative analysis of
the invasion assay is shown in Fig. 2.
Detection of EBV DNA by PCR
PCR results for the detection of EBV DNA in NPC-BM1,
NPC-BM00 and NPC-BM29 are shown in Fig. 3. The prim-
ers that were chosen to amplify the EBNA-3C gene encom-
pass a strain-specific deletion [25]. Amplification with
EBNA-3C primers resulted in the expected 153 bp frag-
ment from B95-8 (Fig. 3A, lane 1) and a 246 bp fragment
from AG876 (Fig. 3A, lane 2). In contrast, the EBV DNA
was not detected in the parental cell line NPC-BM1 (lane
3) neither in the sublines, NPC-BM00 (lane 4) and NPC-
BM29 (lane 5). The BamHI W region is repeated 7 - 12
times in the EBV genome, making it a sensitive target for
detecting EBV in samples where small viral copy numbers
might be expected. The expected size fragment (125 bp) of
BamHI W with the primers used was detected only in the
control samples (Fig. 3B, lanes 1 and 2), but were not
detected in NPC-BM1, NPC-BM00 and NPC-BM29 (lanes
3, 4, and 5).
Morphological changes
It has been reported that "epithelial to mesenchymal tran-
sition" (EMT), the process of transdifferentiation from
epithelial type to mesenchymal phenotype, is one of the
major events during the acquisition of the invasive pheno-
type in tumors of epithelial origin. We studied whether
the more invasive cells also acquired the EMT morphol-
ogy. Under the light microscopy, we found that the mor-
phology of NPC-BM1 (Fig. 4A) exhibited a typical, well-
attached polygonal epithelial cell morphology with few
round and packed appearance cells (arrows) representing
EMT morphology. In contrast, NPC-BM18 (Fig. 4B) was
heterogeneous, ranging from refractile, spindle-shaped
cells with monopolar and occasional bipolar, cytoplasmic
processes, to elongated fibroblast-like cells, with increas-
ing numbers of EMT cells (arrows). Upon the second
round of selection by Matrigel, the numbers of EMT cells
were much enriched in NPC-BM29 (Fig. 4C).
Cell proliferation in low serum medium and soft agar assay
NPC-BM00 and NPC-BM29 were routinely maintained in
the DMEM supplemented with 10% FBS. Under these cul-
ture conditions, both NPC-BM00 and NPC-BM29 grew at
the similar rate (Fig. 5A). The population doubling time
for NPC-BM00 and NPC-BM29 were approximately 18.7
h and 18.2 h, respectively, with no statistically significant
difference (p > .05). Upon transferring the cells into a low
serum (2% FBS) growth medium, the NPC-BM29 cells
exhibited an increase in growth rate compared to NPC-
BM00 cells (Fig. 5B). The population doubling time was
approximately 26.8 h for NPC-BM29 cells and 30.7 h for
NPC-BM00 cells (p < .05). The total cell numbers at the
saturation density in 10% serum compared to that of in
2% serum were approximately 2.5- and 3.7-fold for NPC-
BM29 and NPC-BM00, respectively.
Anchorage-independent growth assays revealed a marked
reduction in colony-formation ability of NPC-BM00 cells
compared to NPC-BM29 cells (Fig. 6). The most signifi-
cant difference in colony forming ability was observed in
the wells plated with 5000 and 10000 cells grown in 2.5%
FBS.
Determination of cell motility and TPA effect
To compare the motility of NPC-BM00 and NPC-BM29,
cells were cultured in the presence and absence of TPA and
Quantitation of migrated cells Figure 2
Quantitation of migrated cells. Cells (1 × 104) were 
plated on the Matrigel. After 48 h, the invasive cells were 
stained with Diff-Quick solution. The number of invasive cells 
was counted from three different fields.
P <0 . 0 5
NPC-BM1 NPC-BM18 NPC-BM29 NPC-BM00
*
*
*
*
*
Detection of EBV DNA by polymerase chain reaction Figure 3
Detection of EBV DNA by polymerase chain reaction. 
Panel A, a fragment of 153 bp and 246 bp of EBNA-3C were 
detected in B95-8 (lane 1) and AG876 (lane 2); NPC-BM1 
(lane 3), NPC-BM00 (lane 4) and NPC-BM29 (lane 5) were all 
negative for EBNA-3C. Panel B, an expected fragment of 125 
bp of BamHI W were detected in B95-8 (lane 1) and AG876 
(lane 2), but not in NPC-BM1, NPC-BM00 and NPC-BM29.
12345
246 bp
153 bp
125 bp
A
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the scrape-wound assay was performed next day. Cells
migrating into a wounded area were studied 7 h after
scraping. As shown in Fig. 7A, the sham-treated control of
NPC-BM00 cells showed slower migration into the
wounded area than that of NPC-BM29 cells (Fig. 7B). In
the presence of TPA, both NPC-BM00 and NPC-BM29
showed increased rate of cell migration into the wounded
area. However, NPC-BM29 consistently exhibited much
faster motility than that of NPC-BM00. Cells at leading
edge did not adhere to each other tightly as seen in the
sham-treated controls in both cases.
Expression of metalloproteinases and invasion
As type IV collagen is one of the integral components of
basement membrane (BM), the uncontrolled expression
of two type IV collagenases, MMP-2 and MMP-9, is
believed to play a critical role in the invasion of BM by
tumor cells [29]. The release of MMP-2, MMP-9, or both
has been associated with metastasis in a variety of tumors.
To correlate the epithelial-mesenchymal transition
changes with the expression of MMP-2 and MMP-9, we
harvested the conditioned medium for gelatin zymogra-
phy analysis. Fig. 8 shows that NPC-BM1 cells secreted a
small amount of MMP-9 into the culture medium (lane
4). In contrast, the amount of MMP-9 released into the
culture medium was increased in NPC-BM18 cells (lane
1) and further increased in NPC-BM29 (lane 2) after a sec-
ond round of selection. However, trace amounts of MMP-
9 were detectable from the medium released from the
non-invasive cells (NPC-BM00) (lane 3). The amount of
MMP-2 secretion among these cell clones was not signifi-
cantly different.
Morphological changes of NPC-BM1 cells after separation of invasive from non-invasive cells Figure 4
Morphological changes of NPC-BM1 cells after separation of invasive from non-invasive cells. Cells were plated in 
low density and photographed after 36 h using light microscopy (× 200 magnification). Panel A, parental cells (NPC-BM1); B, 
cells (NPC-BM18) after the first round of selection; C, cells (NPC-BM29) after the second round of selection. NPC BM1 exhib-
ited typical well-attached polygonal epithelial cell morphology with few round and packed appearance cells (arrows) represent-
ing EMT morphology. These EMT cells increased in NPC-BM18 and NPC-BM29. The epithelial to mesenchymal transition 
(EMT) is characterized by the loss of epithelial characteristics and the gain of mesenchymal attributes in epithelial cells. Panels 
(A) and (C) are the higher power view of panels A and C. Magnification 450 ×.
BC A
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Downregulation of E-cadherin and β-catenin
We studied whether the expression of E-cadherin and its
associated protein, β-catenin, correlated with the mor-
phological changes and invasive properties of NPC-BM00
and NPC-BM29 cells. In Western blot analysis we found
that the expression of E-cadherin was decreased in NPC-
BM29 cells as compared to that expressed in the non-inva-
sive NPC-BM00 cells (Fig. 9A.). It should be noted that the
expression of E-cadherin remains unchanged in different
passages within the same cell line. Concomitant with the
downregulation of expression of E-cadherin, the expres-
sion of β-catenin was also decreased in NPC-BM29 (Fig.
9B).
Overexpression of Ets1 in NPC-BM29 cells
Ets1 is a member of Ets transcription factor family and rec-
ognizes specific nucleotides sequences with a GGAA/T
core sequence [30]. Expression of Ets1 in tumor cells has
been found to correlate with the grade of invasiveness
[31]. To compare the expression level of Ets1, we per-
formed Western blot analysis using Ets1 monoclonal anti-
body. As shown in Fig. 9C, the expression of Ets1 in NPC-
BM29 was markedly increased.
Contrasting immunophenotypic characteristics between 
NPC-BM00 and NPC-BM29
A panel of monoclonal antibodies specific for cell surface
markers and cellular tumor-associated molecules were
used to characterize NPC-BM00 and NPC-BM29 cells. The
results of this assay are shown in Table 1. In this assay,
data were collected and expressed as the % positive cells
and relative mean fluorescence intensity. Among these
molecules investigated, AE3, MAK6 (a mixture of cytok-
eratins 8, 14, 15, 16, 18, and 19), and sialyl-Tn were sig-
nificantly upregulated in NPC-BM29 cells, whereas the
expression of CD54 were significantly increased in NPC-
BM00 cells. Interestingly, HLA-DR was selectively
expressed by NPC-BM00.
Immunophenotypic features of NPC-BM1 that distin-
guishes it as NPC is presented in Table 2. It is clearly
shown that the SCID mouse xenograft of NPC-BM1 cells
exhibited similar immunostaining features as the bone
marrow aspirate from which the NPC-BM1 cell line was
derived, aside from the fact that both tissues displayed
poorly differentiated histopathology (not shown). Posi-
tive staining of HLA-DR was observed in a significant pro-
portion of tumor cells in both tissues. In sharp contrast,
HLA-DR was not expressed in the cell lines derived from
primary NPC lesions, such as NPC039, NPC076, NPC-BR,
CNE-1 and CNE-2, which have been maintained in our
laboratory [32].
Cytokine expression profiles
The cytokines released into the cultured media were meas-
ured on d 1, 3, and 5. Fig. 10 shows the cytokine expres-
sion profiles. On day 1, NPC-BM29 consistently released
higher levels of IL-6, IL-8, IL-10, and IL-13 than NPC-
BM00 cells. There was no difference in the expression level
of IL-2a in both cell lines. On d 3 the production of IL-6
by NPC-BM00 was markedly increased to approximately
3-fold higher than that released by NPC-BM29. However,
Effect of low-serum medium on cell proliferation of NPC-BM00 and NPC-BM29 cells Figure 5
Effect of low-serum medium on cell proliferation of NPC-BM00 and NPC-BM29 cells. To compare the growth 
rate, both NPC-BM00 and NPC-BM29 were seeded and cultured in 2% FBS. The cell proliferation was monitored daily for 8 
days. NPC-BM29 grew better in low serum medium than NPC-BM00.
Doubling Time (h) B A
18.7
18.2
Doubling Time (h)
30.7
26.8Journal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
Page 8 of 14
(page number not for citation purposes)
the production of IL-8, IL-10, and IL-13 on d 3 remained
at similar levels as on d 1. On d 5, both cell lines main-
tained similar high levels of IL-6 production. Despite the
fluctuation of expression level of IL-6, it is of interest to
note that NPC-BM29 consistently released higher levels of
IL-8 and IL-10 in a time-dependent manner throughout
the entire period of assays. In contrast, NPC-BM00 cells
consistently produced a higher level of VEGF than NPC-
BM29 cells (Fig. 11).
Discussion
We had previously established a cell line, NPC-BM1,
derived from a bone marrow biopsy of a female Taiwan-
ese patient with NPC [24]. Some basic differences in base-
line secretion of IL-6, IL-6 receptor α and IFN-γ between
NPC-BM1 and other NPC cell lines derived from primary
tumors have recently been documented [33]. In the cur-
rent study, this parental cell line was further separated to
non-invasive and highly invasive cells, designed NPC-
BM00 and NPC-BM29, respectively. After separation, the
metastatic phenotype of these two cell lines was con-
firmed by cell morphology change suggestive of EMT.
While NPC-BM00 cells exhibited typical well-attached
polygonal epithelial cell morphology, NPC-BM29 was
more heterogeneous and included cells that were spindle-
shaped cells and those resembled fibroblasts.
EMT is characterized by the loss of epithelial characteris-
tics and the gain of mesenchymal attributes. It has been
associated with physiological and pathological processes
requiring epithelial cell migration and invasion. In addi-
tion, evidence is mounting suggesting the importance of
EMT pathways in the progression of carcinoma to metas-
tasis by providing epithelial tumor cells with the ability to
migrate, invade the surrounding stroma and disseminate
in secondary organs [34]. It has been reported that EMT is
one of the major events during the acquisition of the inva-
sive phenotype in tumors of epithelial origin [8,35]. This
process is often accompanied by expression of mesenchy-
mal markers and loss of epithelial markers, especially E-
cadherin, which is one of the most commonly observed
changes in invasive and metastatic carcinomas [36,37].
In the scrape-wound assay, we showed that NPC-BM00
cells exhibit slower migration into the wounded area than
its counterpart NPC-BM29. This observation was further
Anchorage-independent cell growth by soft agar assay Figure 6
Anchorage-independent cell growth by soft agar assay. Soft agar assay was used to compare the colony forming ability 
of NPC-BM00 and NPC-BM29 cells in medium containing different concentrations of fetal calf serum (FBS) and cell numbers. 
Both the NPC-BM00 and NPC-BM29 cells were seeded with 1250, 2500, 5000 and 10000 cells per well in 24-well plates. The 
colonies were counted after 6 days of culture. Data are presented as the means ± standard deviation from experiments that 
were performed in triplicate wells. * referred to the level of significance at P < .05 and # P > .05.Journal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
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supported by the findings demonstrating downregulation
of E-cadherin and its associated protein β-catenin in NPC-
BM29 cells (Fig. 9). Previously we showed that TPA is a
highly potent activator of EBV genome replication
[27,28]. TPA also has been shown to activate some iso-
forms of the important signaling enzyme, protein kinase
C (PKC) [38], which interferes with both cell proliferation
and cell adhesion in a variety of cell types [39]. Various
studies have demonstrated the involvement of PKC in dis-
assembly of E-cadherin-dependent cell-cell adhesion [39-
42]. In the present study, we analyzed the effect of TPA on
cell motility and revealed that both NPC-BM00 and NPC-
BM29 showed increased rate of cell migration into the
wounded area compared to the sham-treated cells but
with differential rate. Activation with TPA also resulted in
a decrease in the level of E-cadherin in both cases (our
unpublished data). Based on these results, we conclude
that PKC activation is involved in TPA-induced cell motil-
ity.
E-cadherin and β-catenin are another commonly
employed index for the epithelial state. These cell adhe-
Scrape-wound migration assay Figure 7
Scrape-wound migration assay. Confluent monolayers of NPC-BM00 and NPC-BM29 were grown in the presence and 
absence of tumor promoting agent TPA and were scraped by a plastic pipette. The wound-induced cell motility was observed 
after 7 h. Panel A, NPC-BM00 and NPC-BM29 cells in the presence and absence of TPA at 0 h after scraping; Panel B, cell 
motility 7 h after scraping. Magnification, 150 ×.
BM-00 0h BM-00 + TPA 0h BM-29 0h BM-29 + TPA 0h
BM-00 7h BM-00 + TPA 7h BM-29 7h BM-29 + TPA 7h
A
B
Differential expression of MMP-9 by the NPC-BM1 parental  line and its sublines (NPC-BM00. --BM18, -BM280) detected  by gelatin zymography Figure 8
Differential expression of MMP-9 by the NPC-BM1 
parental line and its sublines (NPC-BM00. --BM18, -
BM280) detected by gelatin zymography. Cells were 
cultured for 3 days and the condition media were harvested 
and processed for gelatin zymography analysis as described in 
Materials and Methods. Lane 1, conditioned medium from 
NPC-BM18; lane 2, from NPC-BM29; lane 3, from NPC-
BM00; lane 4, from parental cell NPC-BM1.
MMP-9
MMP-2
92 kDa
77 kDa
NPC-BM18
NPC-BM29
NPC-BM00
NPC-BM1Journal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
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sion molecules are localized in the adherence junctions.
These cell-cell adhesion-related criteria are almost exclu-
sively absent in mesenchymal cells. The E-cadherin plays
a central part in the process of epithelial morphogenesis.
Expression of this protein is downregulated during the
acquisition of metastatic potential at late stages of epithe-
lial tumor progression. In cancer, the maintenance of epi-
thelia is lost, and dissociation of cells is associated with
metastatic dissemination. Dissociation of cells can occur
through a decrease in the local expression level of E-cad-
herin.
Invasion and metastasis are determinative features in the
pathogenesis and progression of malignant neoplasms.
The pathogenesis of metastasis consists of multiple,
sequential, selective and interdependent steps. To estab-
lish a metastatic focus, tumor cells must detach from the
primary tumor (suppression of cell-to-cell and cell-matrix
adhesion), degrade and invade the extracellular matrix
(ECM), increase in cell motility and enter the circulation,
arrest in a capillary bed, gain entrance into organ paren-
chyma, proliferate and induce angiogenesis [43]. It is now
well established that the processes of invasion and angio-
genesis are essential for the growth and metastasis of both
primary and metastatic tumors [12].
Matrix metalloproteinases (MMPs) are a family of struc-
turally related zinc-dependent endopeptidases collec-
tively capable of degrading essentially all components of
ECM. Based on their structure and substrate specificity,
MMPs are classified into subgroups of collagenases:
stromelysins and stromelysin-like MMPs and other MMPs
[44]. MMPs play an important role in the physiologic deg-
radation of ECM, e.g., in tissue morphogenesis, tissue
repair and in angiogenesis. MMPs also have important
functions in pathologic conditions characterized by exces-
sive degradation of ECM, such as rheumatoid arthritis,
osteoarthritis, periodontitis, autoimmune blistering dis-
orders of the skin, as well as in tumor invasion and metas-
tasis [44-47]. MMP-1 (collagenase-1) cleaves fibrillar
collagens with preference for type III collagen, which
denatures into gelatin and is further degraded by other
MMPs, such as gelatinases. MMP-2 (gelatinase-A) and
MMP-9 (gelatinase-B) can both degrade the type IV colla-
gen of basement membranes, the first barrier to tumor
invasion. Thus, high expression levels of certain MMPs
facilitate tumor cell invasion and metastasis. Our results
revealed that after separation, the metastasis potential of
NPC-BM29 was confirmed by increased expression of 92-
kDa type IV collagenases/gelatinase B (MMP-2 and MMP-
9); both enzymes are involved in tumor cell invasion and
metastasis.
Ets1 is a member of Ets transcription factor family and rec-
ognizes specific nucleotides sequences with a GGAA/T
core specific sequence [30]. Physiologically, Ets1 is
expressed in various mesodermal derivatives, such as
endothelial cells and mesenchymal cells, but is also
induced in dissociating epithelial cells, during EMT proc-
ess occurring in early development and oncogenic trans-
formation to acquire invasive features [30,48]. Ets1
expression in tumor cells has been found to correlate with
the grade of invasiveness in human tumor tissues [49] and
correlates with a degree of invasiveness in breast cancer
cell lines [48]. Ets family members were reportedly
involved in the control of cell motility and invasion dur-
ing normal tubular morphogenesis and cancerous scatter-
ing in mammary epithelial cells [50]. Furthermore, it has
been reported that MMP9 gene promoter contains a bind-
ing site for Ets in addition to AP-1 and NF-kB, and thus
Ets1 may positively regulate MMP9 gene expression [51].
Therefore, Ets1 may stimulate transcription of many genes
associated with tumor invasion and metastasis, and
would be an effective target in preventing invasion of
malignant tumors.
Using Western blot analysis, we have identified that the
expression of E-cadherin and β-catenin was decreased
Down-regulation of intracellular adhesion molecules E-cad- herin and -catenin in NPC-BM clones Figure 9
Down-regulation of intracellular adhesion molecules 
E-cadherin and -catenin in NPC-BM clones. E-cadherin 
and β-catenin in cell lysates of NPC-BM00, NPC-BM29 and 
NPC-BM18 were analyzed by Western blot using mono-
clonal antibodies specific for these molecules. Specific West-
ern blot signals were visualized on an X-ray film by incubating 
with ECL-Plus chemiluminescence reagents. Panel A, E-cad-
herin; panel B, -catenin. The expression of E-cadherin 
remained unchanged in cells of different passages. Upregula-
tion of transcriptional factor Ets1 was detected in NPC-
BM29 cells (panel C). Both NPC-BM00 and NPC-BM29 cells 
were processed for Western blot analysis the same way as 
done for E-cadherin and -catenin except the monoclonal 
antibody specific for Ets1 was used.
1     2     3      1      2     3     1      2
E-cadherin 120 kDa
(A)
passage
-Actin
NPC-BM29
NPC-BM00
NPC-BM18
(B)
-Actin
-catenin
NPC-BM00
NPC-BM29 (C)
-Actin
Ets1
NPC-BM00
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with the increasing metastatic potential of NPC-BM29
cells. Concomitant with the downregulation of E-cad-
herin and β-catenin, upregulation of the transcription fac-
tor Ets1 was detected in NPC-BM29 cells, in agreement
with the central role of these molecules in the transition
of EMT.
We observed that NPC-BM1 cells formed compact cell
islands in tissue culture plates, remained in tight cell-cell
contacts and exhibited the typical morphology of epithe-
lial cells. In sharp contrast, NPC-BM18 and 29 cells were
scattered and exhibited the typical morphology of mesen-
chymal fibroblasts, suggesting that the constitutive activa-
tion of β-catenin signaling might induce EMT [8].
It has been well-documented that the transformed cells do
not require high concentration of serum in the culture
medium to support the proliferation. In this study, we
demonstrated that serum deprivation markedly retarded
the growth of NPC-BM00 cells with little or no metastatic
Table 1: Immunophenotypic characteristics of two NPC variants BM-00 and BM-29 isolated from the NPC-BM1 cell line.
Monoclonal antibody BM-00 BM-29
Cell surface Cytoplasmic Cell surface Cytoplasmic
HLA-A, B, C 96.6 (70.0) 99.5 (98.8) 98.2 (52.9) 93.2 (40.1)
HLA-DR 37.9 (43.7) 44.2 (38.9) 0.16 (42.3) 0.8
NMIgG 1.0 1.6 1.0 0.4
PBS 0.9 0.6 0.9 1.0
EMA 8.0 82.7 (24.5) 5.9 75.2 (18.9)
AE1 ND 54.5 (36.5) ND 40.5 (23.2)
AE3 ND 28.5 (9.7) ND 44.2 (8.4)
MAK6 ND 17.8 (9.7) ND 28.7 (8.5)
CK7 ND 97.6 (57.8) ND 99.9 (55.1)
CK20 ND 37.7 (13.7) ND 31.8 (11.4)
EpCAM (ESA) 98.7 (54.5) ND 93.8 (39.3) ND
Sialyl-Tn 2.6 5.2 7.8 34.1 (14.5)
Ley 0 . 51 . 20 . 80 . 8
BH8.23(50-55 kDa) 6.5 77.3 (32.5) 6.4 95.4 (33.8)
CEA ND 9.5 ND 4.8
Vimentin ND 97.7 (84.6) ND 99.9 (92.1)
VEGF ND 98.7 (29.4) ND 99.7 (31.8)
CD44s 89.7 (20.3) ND 90.0 (26.8) ND
CD54 95.7 (36.3) ND 87.6 (23.8) ND
CD58 80.8 (10.6) ND 99.2 (31.0) ND
Results are obtained by immunofluorescence and flow cytometric analysis and are expressed as % positive cells and relative mean fluorescence 
intensity (in the bracket). Note that those results with <10% positive cells are considered negative and thus values of mean fluorescence intensity 
are not given.
Abbreviations: ND, not determined; NMIgG, normal mouse Ig; PBS, phosphate-buffered saline; EMA, epithelial membrane antigen; CK, cytokeratin, 
EpCAM, epithelial cellular adhesion molecule; ESA, epithelial specific antigen; Ley. Lewis Y; CEA, embryonic carcinoma antigen; VEGF, vascular 
endothelial growth factor.
Table 2: Comparison of immunophenotypic features of NPC-BM1 cells and the original bone marrow aspirate
Monoclonal antibody Xenograft (section) Bone marrow aspirate (cytospin)
HLA-A, B, C ++++* ++++
HLA-DR ++ (focal) ++ (scattering)
NMIgG - -
PBS - -
EMA +++ +++
AE1 ++ ++
CK7 ++++ ++++
EpCAM (EPS) ++++ ++++
Ley --
Immunostaining of the SCID mouse xenograft resulting from s. c. injection of NPC-BM1 cells and the original bone marrow biopsy (cytospin cells) 
from which the NPC-BM1 cell line was established.
*Results are expressed by the extent of immunostaining on tumor cells. See the footnote of Table 1 for the abbreviations of the markers tested.Journal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
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potential, but had no significant impact on NPC-BM29
cells likely to have higher metastatic potential (Fig. 5).
This phenomenon suggests the possibility that NPC-
BM00 cells may convert the cell phenotype toward
benign, because serum-independent proliferation gener-
ally is accepted as a hallmark of tumor cells but not nor-
mal cells. Indeed, this speculation is supported further by
the observation that significantly fewer colonies were
formed in soft agar by NPC-BM00 than by NPC-BM29
cells (Fig. 6).
The preferential expression of sialyl-Tn by NPC-BM29
cells on one hand and the selective expression of HLA-DR
by NPC-BM00 cells on the other in a significant propor-
tion of cell population are interesting. While the implica-
tions of these results are not immediately clear, further
investigations on both observations are warranted.
Angiogenesis is a key step in tumor growth, invasion and
metastasis. Massive formation of blood vessels at the
tumor site increases the opportunity for tumor cells to
enter the circulation. Thus, microvessel density is consid-
ered to influence tumor metastasis and consequently
prognosis in various human cancers [52]. VEGF, FGF basic
(bFGF) and IL-8 are prominent angiogenic molecules.
These molecules have been demonstrated to influence
microvessel synthesis in various tumors [53,54]. The asso-
ciations of neovascularization to both angiogenic and
lymphatic metastases have been examined in many malig-
nant tumors, and the contributions of angiogenic mole-
cules such as VEGF, bFGF, and IL-8 to the metastatic
potential of tumors have been well documented. The rel-
evance of angiogenic factors to the angiogenesis of these
NPC cell lines described in this study was evaluated by
studying the relationships of IL-8 and VEGF expression.
Our results clearly indicate that the higher level expression
of IL-8 in NPC-BM29 was significantly correlated to its
invasive and metastatic potential. In contrast, the upregu-
lation of VEGF was found in NPC-BM00 cells suggesting
that it may enhance the growth capability by facilitating
neovascularization locally.
The roles of EBV infection in the tumorigenesis of NPC are
of interest because of the close association of this virus
with NPC. Recent reports indicate that EBV LMP-1 is capa-
ble of inducing a wide range of cellular factors associated
with metastatic character of NPC [13-22]. However, the
The cytokine expression profiles of NPC-BM00 and NPC- BM29 cells Figure 10
The cytokine expression profiles of NPC-BM00 and 
NPC-BM29 cells. The cultured media from NPC-BM00 and 
NPC-BM29 cells were collected and analyzed by the Q-
Plex™ Human Cytokine Array for a panel of 12 distinct 
cytokines as described in the text. The cytokine expression 
profiles were monitored and analyzed from cultured media 
collected on day 1, 3, and 5.
NPC-BM00
NPC-BM29
Detection of VEGF production by ELISA Figure 11
Detection of VEGF production by ELISA. The cultured 
media from NPC-BM00 and NPC-BM29 cells were collected 
and analyzed by ELISA using VEGF monoclonal antibody 
coated on the microtiter plate. The VEGF expression profiles 
were monitored and analyzed from cultured media collected 
on day 1, 3, and 5.
Time (Day)Journal of Biomedical Science 2009, 16:105 http://www.jbiomedsci.com/content/16/1/105
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critical functions of EBV in NPC development remain
poorly understood. It has been noted that the EBV
genome is commonly lost during the establishment of
NPC cell lines from biopsies or xenografts [23]. However,
EBV genomes are not lost from tumors being propagated
in nude mice. Such tumors retain characteristics of the
original NPC including p53 negativity. The loss of EBV
genomes during attempts to culture NPC in vitro is associ-
ated with inability to establish cell lines from original or
nude-mouse passaged tumors.
It should be noted that both the parental cell line (NPC-
BM1) and two sublines (NPC-BM00 and NPC-BM29) are
EBV-negative (Fig. 3). This observation suggests that EBV
may have other important roles in vivo, which may
include, but are not limited to, conferring protection to
the carcinoma cells from immune surveillance [55].
Overall, this study reports our observations on important
cellular signaling cascades that are associated with metas-
tasis of NPC in the absence of EBV genome. The link
between morphologic changes from epithelial to mesen-
chymal transition and identification of the molecules
associated with these changes opens up new avenues in
cancer research, allowing the use of these molecular mark-
ers to pave the way for the identification of novel targets
for therapeutic intervention of invasion and metastasis.
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